Matches in SemOpenAlex for { <https://semopenalex.org/work/W2784578081> ?p ?o ?g. }
- W2784578081 endingPage "5268" @default.
- W2784578081 startingPage "5255" @default.
- W2784578081 abstract "The high drug-loading and excellent biocompatibilities of metal–organic frameworks (MOFs) have led to their application as drug-delivery systems (DDSs). Nanoparticle surface chemistry dominates both biostability and dispersion of DDSs while governing their interactions with biological systems, cellular and/or tissue targeting, and cellular internalization, leading to a requirement for versatile and reproducible surface functionalization protocols. Herein, we explore not only the effect of introducing different surface functionalities to the biocompatible Zr-MOF UiO-66 but also the efficacy of three surface modification protocols: (i) direct attachment of biomolecules [folic acid (FA) and biotin (Biot)] introduced as modulators for UiO-66 synthesis, (ii) our previously reported “click-modulation” approach to covalently attach polymers [poly(ethylene glycol) (PEG), poly-l-lactide, and poly-N-isopropylacrylamide] to the surface of UiO-66 through click chemistry, and (iii) surface ligand exchange to postsynthetically coordinate FA, Biot, and heparin to UiO-66. The innovative use of a small molecule with metabolic anticancer activity, dichloroacetate (DCA), as a modulator during synthesis is described, and it is found to be compatible with all three protocols, yielding surface-coated, DCA-loaded (10–20 w/w %) nano-MOFs (70–170 nm). External surface modification generally enhances the stability and colloidal dispersion of UiO-66. Cellular internalization routes and efficiencies of UiO-66 by HeLa cervical cancer cells can be tuned by surface chemistry, and anticancer cytotoxicity of DCA-loaded MOFs correlates with the endocytosis efficiency and mechanisms. The MOFs with the most promising coatings (FA, PEG, poly-l-lactide, and poly-N-isopropylacrylamide) were extensively tested for selectivity of anticancer cytotoxicity against MCF-7 breast cancer cells and HEK293 healthy kidney cells as well as for cell proliferation and reactive oxygen species production against J774 macrophages and peripheral blood lymphocytes isolated from the blood of human donors. DCA-loaded, FA-modified UiO-66 selectively kills cancer cells without harming healthy ones or provoking immune system response in vitro, suggesting a significant targeting effect and great potential in anticancer drug delivery. The results provide mechanistic insight into the design and functionalization of MOFs for drug delivery and underline the availability of various in vitro techniques to potentially minimize early-stage in vivo animal studies following the three Rs: reduction, refinement, and replacement." @default.
- W2784578081 created "2018-02-02" @default.
- W2784578081 creator A5003311345 @default.
- W2784578081 creator A5009817313 @default.
- W2784578081 creator A5010931769 @default.
- W2784578081 creator A5030442542 @default.
- W2784578081 creator A5045993404 @default.
- W2784578081 creator A5076224742 @default.
- W2784578081 creator A5081651773 @default.
- W2784578081 date "2018-02-02" @default.
- W2784578081 modified "2023-10-18" @default.
- W2784578081 title "Mechanistic Investigation into the Selective Anticancer Cytotoxicity and Immune System Response of Surface-Functionalized, Dichloroacetate-Loaded, UiO-66 Nanoparticles" @default.
- W2784578081 cites W1955562881 @default.
- W2784578081 cites W1960975929 @default.
- W2784578081 cites W1968377063 @default.
- W2784578081 cites W1976463363 @default.
- W2784578081 cites W1985076352 @default.
- W2784578081 cites W1985969082 @default.
- W2784578081 cites W1986238480 @default.
- W2784578081 cites W1986568717 @default.
- W2784578081 cites W1992215904 @default.
- W2784578081 cites W1995543353 @default.
- W2784578081 cites W1995980440 @default.
- W2784578081 cites W1996352962 @default.
- W2784578081 cites W1997889992 @default.
- W2784578081 cites W2018971639 @default.
- W2784578081 cites W2028897202 @default.
- W2784578081 cites W2032297029 @default.
- W2784578081 cites W2032760352 @default.
- W2784578081 cites W2033958147 @default.
- W2784578081 cites W2038904846 @default.
- W2784578081 cites W2041105700 @default.
- W2784578081 cites W2045016772 @default.
- W2784578081 cites W2063482702 @default.
- W2784578081 cites W2063687158 @default.
- W2784578081 cites W2064405498 @default.
- W2784578081 cites W2066991705 @default.
- W2784578081 cites W2069537362 @default.
- W2784578081 cites W2077300098 @default.
- W2784578081 cites W2085854250 @default.
- W2784578081 cites W2086338662 @default.
- W2784578081 cites W2090892913 @default.
- W2784578081 cites W2091385634 @default.
- W2784578081 cites W2093094256 @default.
- W2784578081 cites W2107344128 @default.
- W2784578081 cites W2113510568 @default.
- W2784578081 cites W2128473487 @default.
- W2784578081 cites W2131762032 @default.
- W2784578081 cites W2136435324 @default.
- W2784578081 cites W2137374477 @default.
- W2784578081 cites W2141939342 @default.
- W2784578081 cites W2149279554 @default.
- W2784578081 cites W2151260260 @default.
- W2784578081 cites W2152572574 @default.
- W2784578081 cites W2166740797 @default.
- W2784578081 cites W2166984808 @default.
- W2784578081 cites W2208284809 @default.
- W2784578081 cites W2216884021 @default.
- W2784578081 cites W2283564633 @default.
- W2784578081 cites W2297417682 @default.
- W2784578081 cites W2315956629 @default.
- W2784578081 cites W2320312730 @default.
- W2784578081 cites W2323598567 @default.
- W2784578081 cites W2325249605 @default.
- W2784578081 cites W2330408069 @default.
- W2784578081 cites W2343649717 @default.
- W2784578081 cites W2465873334 @default.
- W2784578081 cites W2547848453 @default.
- W2784578081 cites W2577565314 @default.
- W2784578081 cites W2579451396 @default.
- W2784578081 cites W2602228571 @default.
- W2784578081 cites W2603383977 @default.
- W2784578081 cites W2608941817 @default.
- W2784578081 cites W2614976445 @default.
- W2784578081 cites W2616315981 @default.
- W2784578081 cites W2738131416 @default.
- W2784578081 cites W2742745499 @default.
- W2784578081 cites W2755407020 @default.
- W2784578081 cites W2763102370 @default.
- W2784578081 cites W596767445 @default.
- W2784578081 doi "https://doi.org/10.1021/acsami.7b17756" @default.
- W2784578081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29356507" @default.
- W2784578081 hasPublicationYear "2018" @default.
- W2784578081 type Work @default.
- W2784578081 sameAs 2784578081 @default.
- W2784578081 citedByCount "78" @default.
- W2784578081 countsByYear W27845780812018 @default.
- W2784578081 countsByYear W27845780812019 @default.
- W2784578081 countsByYear W27845780812020 @default.
- W2784578081 countsByYear W27845780812021 @default.
- W2784578081 countsByYear W27845780812022 @default.
- W2784578081 countsByYear W27845780812023 @default.
- W2784578081 crossrefType "journal-article" @default.
- W2784578081 hasAuthorship W2784578081A5003311345 @default.
- W2784578081 hasAuthorship W2784578081A5009817313 @default.
- W2784578081 hasAuthorship W2784578081A5010931769 @default.
- W2784578081 hasAuthorship W2784578081A5030442542 @default.
- W2784578081 hasAuthorship W2784578081A5045993404 @default.